Halozyme Therapeutics Inc (HALO)

[maumar]

Okay, thanks.

"The question is what price the company's cash flows can support"

I think the price is affected by how heavily dependent we are on Darzalex. Fortunately, we have milestone payments. But a more diverse revenue stream, at least as far as royalties are concerned, would lower the risk and the market would assign a higher PE. That is why I think Phesgo and visibility into new products are important.